Clinical Trial Update: Everolimus Versus Placebo in Head and Neck Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial comparing everolimus to placebo in head and neck cancer has terminated; results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Drugs mentioned

• Everolimus (everolimus)

Snippet

Sponsor: University of Chicago | Conditions: Head and Neck Cancer | Phase 2 | Status: TERMINATED | Results posted: 2020-04-07